Patient#	Sample#	GDP:(GTP, active),(Gi family/GNB1/GNG2/GDP, active),	GNB1/GNG2:(GTP, active),(Gi family/GNB1/GNG2/GDP, active),	AKT1:(AKT1, protein),	CK1 family:(CK1 family, protein),	CREBBP:(CREBBP, protein),	GLI family:(GLI family, protein),	GSK3B:(GSK3B, protein),	Galectin3:(Galectin3, protein),	IFT172:(IFT172, protein),	MAP2K1:(MAP2K1, protein),(SHH Np/Cholesterol, active),	MTSS1:(MTSS1, protein),	PKC delta:(PKC delta, protein),(SHH Np/Cholesterol, active),	PRKACA:(PRKACA, protein),	Polaris:(Polaris, protein),	SMO:(SMO, protein),	SPOP:(SPOP, protein),	STK36:(STK36, protein),	XPO1:(XPO1, protein),	GLI family-active:(GLI family, active),(GLI family-active, protein),(SMO/beta Arrestin2, active),	GLI2:(CK1 family, active),(GLI2, protein),(GSK3B, active),(PRKACA, active),	Gi family/GTP:(GTP, active),(Gi family/GNB1/GNG2/GDP, active),(SMO, active),	KIF3A:(KIF3A, protein),	PIAS1:(PIAS1, protein),	RAB23:(RAB23, protein),	embryonic digit morphogenesis:(Polaris, active),	GLI2/SPOP:(GLI2, active),(SPOP, active),	GLI2R:(GLI2, active),(GLI2R, protein),(beta TrCP1/SCF ubiquitin ligase complex, active),	neural tube patterning:(GLI family-active, active),	FOXA2:(FOXA2, protein),	GLI1	MIM/GLI1:(GLI1, active),(MTSS1, active),	GLI1/Su(fu)	GLI2/Su(fu)	GLI2A:(AKT1, active),(GLI2, active),(GLI2/Su(fu), active),(GLI2A, protein),(IFT172, active),(KIF3A, active),(MAP2K1, active),(PKC delta, active),(Polaris, active),(RAB23, active),(SMO/beta Arrestin2, active),(STK36, active),	SUFU:(GLI1/Su(fu), active),(GLI2/Su(fu), active),(SUFU, protein),	MIM/GLI2A:(GLI2A, active),(MTSS1, active),	Su(fu)/Galectin3:(Galectin3, active),(SUFU, active),	Su(fu)/SIN3/HDAC complex:(SIN3/HDAC complex, active),(SUFU, active),	forebrain development:(GLI1, active),(GLI2A, active),	GLI3:(GLI3, protein),(GSK3B, active),(IFT172, active),(KIF3A, active),(PRKACA, active),(Polaris, active),(RAB23, active),(SMO, active),(Su(fu)/SIN3/HDAC complex, active),	Su(fu)/PIAS1:(PIAS1, active),(SUFU, active),	GLI3/SPOP:(GLI3, active),(SPOP, active),	GLI3/Su(fu):(GLI3, active),(SUFU, active),	GLI3A:(GLI3, active),(GLI3A, protein),(SMO, active),	GLI3R:(GLI3, active),(GLI3R, protein),(beta TrCP1/SCF, active),	PTCH1:(PTCH1, protein),	GLI3A/Cbp:(CREBBP, active),(GLI3A, active),	catabolic process:(GLI2/SPOP, active),(GLI3/SPOP, active),	embryonic limb morphogenesis:(GLI1, active),(GLI2A, active),(GLI3R, active),	
